

Author: Zhao Wen-Hua Zhang Jin-Feng Zhang Ying-Xia Tian Wei-Xi
Publisher: Informa Healthcare
ISSN: 1475-6366
Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol.21, Iss.5, 2006-10, pp. : 589-596
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Fatty acid synthase (FAS) has been identified as a potential antitumor target. The extract from the leaves of Acer truncatum Bunge (Extr) was prepared to assay its inhibitory activity against FAS, which was isolated from duck liver, and the correlated antitumor bioactivity. Its inhibition of FAS is composed of reversible fast-binding inhibition, IC50Â=Â0.7Âμg/ml, and irreversible slow-binding inhibition following saturation kinetics with a dissociation constant of 0.68Âμg/ml and a limiting rate constant of 0.0288Âmin−Â1. The Extr exhibited different type of inhibitions against the three substrates in the FAS overall reaction. Compared with EGCG in inhibition constant and IC50 value, the Extr appeared to be a more efficient inhibitor, and exhibited a considerable inhibition against the growth of four kinds of cancer cells (patent application number 200510068054.2). It was infered that the inhibitory activity is likely attributable to the co-operative effect of the components.
Related content






By Wei Xiang Zhao Ran Sun Ying-Hui Cong Jian-Ping Meng Fan-Guo Zhou Hai-Meng
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. :


By Du Ya-Tao Wang Xuan Wu Xiao-Dong Tian Wei-Xi
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 20, Iss. 4, 2005-08 ,pp. :


Fatty Acid Synthase: A Target for the Reversal of Liver Steatosis
Current Enzyme Inhibition, Vol. 4, Iss. 3, 2008-10 ,pp. :